All You Need to Know About Werewolf Therapeutics (HOWL) Rating Upgrade to Buy

3d ago, source: Zacks.com on MSN

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Werewolf Therapeutics Inc (HOWL) Stock: A SWOT Analysis

3d ago, source: newsheater

Smart investors will not be hesitating on this one! Werewolf Therapeutics Inc (NASDAQ: HOWL)’s stock price has gone rise by 17.06 in comparison to its previous close of 4.69, however, the company has ...

Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space

14d ago, source:

Werewolf Therapeutics, Inc. is developing modified cytokines for cancer treatment, including WTX-124 and WTX-330. Click for ...

Werewolf Therapeutics Expands Offering with $25M Stock Sale

2mon ago, source: TipRanks on MSN

Werewolf Therapeutics (HOWL) has released an update. Werewolf Therapeutics, Inc. has filed a prospectus supplement for the ...

How Much Upside is Left in Werewolf Therapeutics, Inc. (HOWL)? Wall Street Analysts Think 92.37%

1mon ago, source: Nasdaq

Shares of Werewolf Therapeutics, Inc. (HOWL) have gained 7% over the past four weeks to close the last trading session at $6.55, but there could still be a solid upside left in the stock if short ...

Buy Rating for Werewolf Therapeutics: Innovation and Financial Stability Signal Promising Future in Immunotherapy

16d ago, source: Business Insider

Werewolf Therapeutics (HOWL) Company Description: Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body ...

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

5mon ago, source: Benzinga.com

Werewolf Therapeutics Inc has a consensus price target of $17.43, established from looking at the 26 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities ...

All You Need to Know About Werewolf Therapeutics (HOWL) Rating Upgrade to Buy

3d ago, source: Nasdaq

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Werewolf Therapeutics Inc HOWL

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Werewolf Therapeutics Inc HOWL

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...